Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stepwise Intensification of BIAsp 30 vs Basal-Bolus in T2DM
NCT02453685Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2015
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 4 trial of biphasic insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Aug 2015; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02453685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453685.